83 related articles for article (PubMed ID: 21868456)
21. Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study.
Han TS; Williams K; Sattar N; Hunt KJ; Lean ME; Haffner SM
Obes Res; 2002 Sep; 10(9):923-31. PubMed ID: 12226141
[TBL] [Abstract][Full Text] [Related]
22. Glucose metabolism in patients with essential hypertension.
García-Puig J; Ruilope LM; Luque M; Fernández J; Ortega R; Dal-Ré R;
Am J Med; 2006 Apr; 119(4):318-26. PubMed ID: 16564774
[TBL] [Abstract][Full Text] [Related]
23. People with impaired glucose tolerance and impaired fasting glucose are similarly susceptible to cardiovascular disease: a study in first-degree relatives of type 2 diabetic patients.
Amini M; Horri N; Zare M; Haghighi S; Hosseini SM; Aminorroaya A; Hovsepian S
Ann Nutr Metab; 2010; 56(4):267-72. PubMed ID: 20413967
[TBL] [Abstract][Full Text] [Related]
24. Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece.
Makrilakis K; Liatis S; Grammatikou S; Perrea D; Stathi C; Tsiligros P; Katsilambros N
Diabetes Metab; 2011 Apr; 37(2):144-51. PubMed ID: 21144787
[TBL] [Abstract][Full Text] [Related]
25. Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events.
Mancia G; Bombelli M; Facchetti R; Casati A; Ronchi I; Quarti-Trevano F; Arenare F; Grassi G; Sega R
J Hypertens; 2010 May; 28(5):999-1006. PubMed ID: 20308922
[TBL] [Abstract][Full Text] [Related]
26. The prevalence of metabolic syndrome in Chinese postmenopausal women and the optimum body composition indices to predict it.
Ruan X; Jin J; Hua L; Liu Y; Wang J; Liu S
Menopause; 2010; 17(3):566-70. PubMed ID: 20054286
[TBL] [Abstract][Full Text] [Related]
27. [Diagnosis of the metabolic syndrome].
Hanefeld M; Willms B
Internist (Berl); 1996 Jul; 37(7):705-11. PubMed ID: 8766264
[No Abstract] [Full Text] [Related]
28. Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population.
Dassanayake AS; Kasturiratne A; Rajindrajith S; Kalubowila U; Chakrawarthi S; De Silva AP; Makaya M; Mizoue T; Kato N; Wickremasinghe AR; de Silva HJ
J Gastroenterol Hepatol; 2009 Jul; 24(7):1284-8. PubMed ID: 19476560
[TBL] [Abstract][Full Text] [Related]
29. Waist circumference has heterogeneous impact on development of diabetes in different populations: longitudinal comparative study between Australia and Iran.
Rostambeigi N; Shaw JE; Atkins RC; Ghanbarian A; Cameron AJ; Forbes A; Momenan A; Hadaegh F; Mirmiran P; Zimmet PZ; Azizi F; Tonkin AM
Diabetes Res Clin Pract; 2010 Apr; 88(1):117-24. PubMed ID: 20096474
[TBL] [Abstract][Full Text] [Related]
30. Non-alcoholic fatty liver disease.
Bhala N; Usherwood T; George J
BMJ; 2009 Jul; 339():b2474. PubMed ID: 19608620
[No Abstract] [Full Text] [Related]
31. Prevalence of metabolic syndrome (METS) using IDF 2005 guidelines in a semi urban south Indian (Boloor Diabetes Study) population of Mangalore.
Pemminati S; Prabha Adhikari MR; Pathak R; Pai MR
J Assoc Physicians India; 2010 Nov; 58():674-7. PubMed ID: 21510460
[TBL] [Abstract][Full Text] [Related]
32. How many components for the metabolic syndrome? Results of exploratory factor analysis in the FIBAR study.
Mannucci E; Monami M; Rotella CM
Nutr Metab Cardiovasc Dis; 2007 Dec; 17(10):719-26. PubMed ID: 17387006
[TBL] [Abstract][Full Text] [Related]
33. [Secondary hyperlipidemia due to obesity and alcohol drinking].
Saito Y
Nihon Naika Gakkai Zasshi; 1992 Nov; 81(11):1784-7. PubMed ID: 1479219
[No Abstract] [Full Text] [Related]
34. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
[TBL] [Abstract][Full Text] [Related]
35. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study.
Wilson PW; Meigs JB; Sullivan L; Fox CS; Nathan DM; D'Agostino RB
Arch Intern Med; 2007 May; 167(10):1068-74. PubMed ID: 17533210
[TBL] [Abstract][Full Text] [Related]
36. [The metabolic syndrome--clinical significance in 2011. Position statement of the Hungarian Diabetes Society, Metabolism Work Group].
Barkai L; Halmos T; Hidvégi T; Jermendy G; Korányi L; Madácsy L; Pados G; Winkler G;
Orv Hetil; 2011 Sep; 152(36):1450-8. PubMed ID: 21865147
[No Abstract] [Full Text] [Related]
37. Should all patients with nonalcoholic fatty liver disease undergo oral glucose tolerance test?
Wong VW; Chan HL
J Gastroenterol Hepatol; 2011 Mar; 26(3):419-20. PubMed ID: 21332536
[No Abstract] [Full Text] [Related]
38. Clinical and laboratory diagnosis of the metabolic syndrome.
Olufadi R; Byrne CD
J Clin Pathol; 2008 Jun; 61(6):697-706. PubMed ID: 18505888
[TBL] [Abstract][Full Text] [Related]
39. [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease].
Kim MY; Baik SK
Korean J Hepatol; 2008 Mar; 14(1):1-3. PubMed ID: 18367852
[No Abstract] [Full Text] [Related]
40. [Metabolic syndrome].
Takata H; Fujimoto S
Nihon Rinsho; 2013 Feb; 71(2):266-9. PubMed ID: 23631204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
